SALIX PHARMACEUTICALS LTD·4

Jul 17, 5:33 PM ET

SALIX PHARMACEUTICALS LTD 4

4 · SALIX PHARMACEUTICALS LTD · Filed Jul 17, 2006

Insider Transaction Report

Form 4
Period: 2006-07-13
Taylor David N MD
VP - Chief Medical Officer
Transactions
  • Award

    Common Stock

    2006-07-13+13,50013,500 total
Holdings
  • Option to Buy Common Stock

    Exercise: $22.76Exp: 2014-09-01Common Stock (100,000 underlying)
    100,000
  • Option to Buy Common Stock

    Exercise: $17.63Exp: 2015-06-09Common Stock (10,500 underlying)
    10,500
Footnotes (3)
  • [F1]Represents restricted stock award which shall vest over 4 years at the rate of 25% on July 1, 2007, and then at the rate of 25% on each anniversary thereafter, subject to continued employment.
  • [F2]Option vests at a rate of 1/48th per month, with a vesting commencement date of July 1, 2005.
  • [F3]Option vests monthly over 48 months, with a 1/4 of the shares vesting on September 1, 2005 and the remainder vesting at a rate of 1/48th per month thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION